These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 22936123)

  • 1. First European case of convulsions related to analytically confirmed use of the synthetic cannabinoid receptor agonist AM-2201.
    McQuade D; Hudson S; Dargan PI; Wood DM
    Eur J Clin Pharmacol; 2013 Mar; 69(3):373-6. PubMed ID: 22936123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suspected synthetic cannabinoid receptor agonist intoxication: Does analysis of samples reflect the presence of suspected agents?
    Tebo C; Mazer-Amirshahi M; DeGeorge L; Gelfand B; Leak C; Tolliver S; Sauter D
    Am J Emerg Med; 2019 Oct; 37(10):1846-1849. PubMed ID: 30595429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical toxicity following analytically confirmed use of the synthetic cannabinoid receptor agonist MDMB-CHMICA. A report from the Identification Of Novel psychoActive substances (IONA) study.
    Hill SL; Najafi J; Dunn M; Acheampong P; Kamour A; Grundlingh J; Blain PG; Thomas SH
    Clin Toxicol (Phila); 2016 Sep; 54(8):638-43. PubMed ID: 27251903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of substance exposure history in patients attending emergency departments after substance misuse; a comparison with biological sample analysis.
    Virmani I; Oteo A; Dunn M; Vidler D; Roper C; Officer J; Hardy G; Dargan PI; Eddleston M; Cooper JG; Hill SL; Macfarlane R; Keating L; Haden M; Hudson S; Thomas SHL
    Clin Toxicol (Phila); 2023 Jan; 61(1):39-46. PubMed ID: 36322622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology and clinical features of toxicity following recreational use of synthetic cannabinoid receptor agonists: a report from the United Kingdom National Poisons Information Service.
    Waugh J; Najafi J; Hawkins L; Hill SL; Eddleston M; Vale JA; Thompson JP; Thomas SH
    Clin Toxicol (Phila); 2016 Jul; 54(6):512-8. PubMed ID: 27091041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Effects of Synthetic Cannabinoid Receptor Agonists Compared with Marijuana in Emergency Department Patients with Acute Drug Overdose.
    Zaurova M; Hoffman RS; Vlahov D; Manini AF
    J Med Toxicol; 2016 Dec; 12(4):335-340. PubMed ID: 27255136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic Cannabinoid-Related Deaths in England, 2012-2019.
    Yoganathan P; Claridge H; Chester L; Englund A; Kalk NJ; Copeland CS
    Cannabis Cannabinoid Res; 2022 Aug; 7(4):516-525. PubMed ID: 33998886
    [No Abstract]   [Full Text] [Related]  

  • 8. Synthetic cannabinoid intoxication: a case series and review.
    Harris CR; Brown A
    J Emerg Med; 2013 Feb; 44(2):360-6. PubMed ID: 22989695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of Nine Synthetic Cannabinoid Receptor Agonists Encountered in Clinical Casework: Major in vivo Phase I Metabolites of AM-694, AM-2201, JWH-007, JWH-019, JWH-203, JWH-307, MAM-2201, UR-144 and XLR-11 in Human Urine Using LC-MS/MS.
    Hutter M; Broecker S; Kneisel S; Franz F; Brandt SD; Auwarter V
    Curr Pharm Biotechnol; 2018; 19(2):144-162. PubMed ID: 29745330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in hospital presentations following analytically confirmed synthetic cannabinoid receptor agonist exposure before and after implementation of the 2016 UK Psychoactive Substances Act.
    Craft S; Dunn M; Vidler D; Officer J; Blagbrough IS; Pudney CR; Henderson G; Abouzeid A; Dargan PI; Eddleston M; Cooper J; Hill SL; Roper C; Freeman TP; Thomas SHL
    Addiction; 2022 Nov; 117(11):2899-2906. PubMed ID: 35665553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical effects of cannabis compared to synthetic cannabinoid receptor agonists (SCRAs): a retrospective cohort study of presentations with acute toxicity to European hospitals between 2013 and 2020.
    Waters ML; Dargan PI; Yates C; Dines AM; Eyer F; Giraudon I; Heyerdahl F; Hovda KE; Liechti ME; Miró Ò; Vallersnes OM; Anseeuw K; Badaras R; Bitel M; Bonnici J; Brvar M; Caganova B; Calýskan F; Ceschi A; Chamoun K; Daveloose L; Galicia M; Gartner B; Gorozia K; Grenc D; Gresnigt FMJ; Hondebrink L; Jürgens G; Konstari J; Kutubidze S; Laubner G; Liakoni E; Liguts V; Lyphout C; McKenna R; Mégarbane B; Moughty A; Nitescu GV; Noseda R; O'Connor N; Paasma R; Ortega Perez J; Perminas M; Persett PS; Põld K; Puchon E; Puiguriguer J; Radenkova-Saeva J; Rulisek J; Samer C; Schmid Y; Scholz I; Stašinskis R; Surkus J; Van den Hengel-Koot I; Vigorita F; Vogt S; Waldman W; Waring WS; Zacharov S; Zellner T; Wood DM
    Clin Toxicol (Phila); 2024 Jun; 62(6):378-384. PubMed ID: 38934347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection and quantitation of synthetic cannabinoid receptor agonists in infused papers from prisons in a constantly evolving illicit market.
    Norman C; Walker G; McKirdy B; McDonald C; Fletcher D; Antonides LH; Sutcliffe OB; Nic Daéid N; McKenzie C
    Drug Test Anal; 2020 Apr; 12(4):538-554. PubMed ID: 31944624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute psychosis associated with recreational use of benzofuran 6-(2-aminopropyl)benzofuran (6-APB) and cannabis.
    Chan WL; Wood DM; Hudson S; Dargan PI
    J Med Toxicol; 2013 Sep; 9(3):278-81. PubMed ID: 23733714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Toxicity Caused by Indole and Indazole Carboxylate Synthetic Cannabinoid Receptor Agonists: From Horizon Scanning to Notification.
    Hill SL; Dunn M; Cano C; Harnor SJ; Hardcastle IR; Grundlingh J; Dargan PI; Wood DM; Tucker S; Bartram T; Thomas SHL
    Clin Chem; 2018 Feb; 64(2):346-354. PubMed ID: 29038156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shape matters: The application of activity-based in vitro bioassays and chiral profiling to the pharmacological evaluation of synthetic cannabinoid receptor agonists in drug-infused papers seized in prisons.
    Antonides LH; Cannaert A; Norman C; NicDáeid N; Sutcliffe OB; Stove CP; McKenzie C
    Drug Test Anal; 2021 Mar; 13(3):628-643. PubMed ID: 33161649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a thermal degradation product of CUMYL-PEGACLONE and its detection in biological samples.
    Nash C; Glowacki L; Gerostamoulos D; Pigou P; Scott T; Kostakis C
    Drug Test Anal; 2019 Oct; 11(10):1480-1485. PubMed ID: 31479592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic cannabinoid receptor agonists-induced recurrent seizure in elderly patient.
    Andreias L; Roffe E; Eng A; Yiu K; Pashmforoosh G; Khan Z; Rahman R; Kalantari H; Hassen GW
    Am J Emerg Med; 2020 Apr; 38(4):850.e5-850.e6. PubMed ID: 31839517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of cannabinoid hyperemesis syndrome caused by synthetic cannabinoids.
    Hopkins CY; Gilchrist BL
    J Emerg Med; 2013 Oct; 45(4):544-6. PubMed ID: 23890687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First reported case in the UK of acute prolonged neuropsychiatric toxicity associated with analytically confirmed recreational use of phenazepam.
    Dargan PI; Davies S; Puchnarewicz M; Johnston A; Wood DM
    Eur J Clin Pharmacol; 2013 Mar; 69(3):361-3. PubMed ID: 22843017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 'Crazy Monkey' poisons man and dog: Human and canine seizures due to PB-22, a novel synthetic cannabinoid.
    Gugelmann H; Gerona R; Li C; Tsutaoka B; Olson KR; Lung D
    Clin Toxicol (Phila); 2014 Jul; 52(6):635-8. PubMed ID: 24905571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.